Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
GTB-3650 / GT Biopharma
NCT06594445: HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML	Not yet recruiting	1	45	NA	GTB-360, anti-CD16/IL-15/anti-CD33	Masonic Cancer Center, University of Minnesota	Myeloid Malignancy, Acute Myeloid Leukemia, Myelodysplastic Syndromes	11/28	11/29